SEMA4C as a Relapse Biomarker in Breast Cancer
Clinical trial NCT03663153 · UNKNOWN
Trial details
- NCT number
- NCT03663153
- Sponsor
- Tongji Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-01
- Primary completion
- 2023-08-01
- Enrollment
- 4200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.